NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

2017-12-06T12:10:33-07:00

MENLO PARK, Calif., April 11, 2017 – NuMedii, Inc. today announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s Big Data intelligence technology. Idiopathic pulmonary fibrosis is a rare chronic progressive and usually fatal interstitial lung disease for [...]